When did NRX PHARMACEUTICALS INC (NRXP) report earnings last quarter?
NRX PHARMACEUTICALS INC (NRXP) last reported earnings on 3/23/2026.
NRX PHARMACEUTICALS INC (NRXP) Earnings History & Surprises
NASDAQ:NRXP • US6294442099
Current stock price
2.25 USD
+0.02 (+0.9%)
At close:
2.25 USD
0 (0%)
Pre-Market:
NRXP Earnings overview
Past quarterly earnings results for NRX PHARMACEUTICALS INC (NRXP), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 13, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.04
- Revenue Estimate
- 14.535M
Last Reported
Most Recent- Release Date
- Mar 23, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.01
- EPS Surprise
- -370.59%
- Revenue Surprise
- -87.19%
Beat Rate
Last 8 Quarters 19%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.01 | 0.00 | -370.59% | 98.44% | 983K | 7.676M | -87.19% | - |
| Q3 2025 | -0.50 | -0.09 | -476.70% | -284.62% | 242K | 6.962M | -96.52% | - |
| Q2 2025 | -0.31 | -0.21 | -49.47% | 53.73% | 1.53M | -100.00% | - | |
| Q1 2025 | -0.21 | -0.31 | 31.37% | 71.62% | 1.16M | -100.00% | - | |
| Q4 2024 | -0.77 | -0.32 | -138.39% | -54.00% | - | - | ||
| Q3 2024 | -0.13 | -0.65 | 80.09% | 81.43% | - | - | ||
| Q2 2024 | -0.67 | -0.71 | 5.49% | 44.17% | - | - | ||
| Q1 2024 | -0.74 | -0.56 | -31.91% | 53.75% | - | - | ||
| Q4 2023 | -0.50 | -0.71 | 29.97% | 68.75% | - | - | ||
| Q3 2023 | -0.70 | -1.16 | 39.44% | 50.00% | - | - | ||
| Q2 2023 | -1.20 | -1.39 | 13.92% | -9.09% | - | - | ||
| Q1 2023 | -1.60 | -1.43 | -12.04% | -661.90% | - | - | ||
| Q4 2022 | -1.60 | -1.48 | -8.18% | -1,677.78% | - | - | ||
| Q3 2022 | -1.40 | -1.43 | 1.96% | -250.00% | - | - | ||
| Q2 2022 | -1.10 | -1.02 | -7.84% | -189.47% | - | - | ||
| Q1 2022 | -0.21 | - | - | - | - | |||
| Q4 2021 | -0.09 | - | - | - | - | |||
| Q3 2021 | -0.40 | - | - | - | - | |||
| Q2 2021 | -0.38 | - | - | - | - | |||
| Q1 2021 | - | - | - | - | ||||
| Q4 2020 | - | - | - | - | ||||
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - | ||||
| Q1 2020 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-216.35%
Max EPS beat (4)
31.37%
Min EPS beat (4)
-476.70%
Revenue beat statistics
Revenue beat (4)
0
Average Revenue beat (4)
-95.93%
Max Revenue beat (4)
-87.19%
Min Revenue beat (4)
-100.00%
Analysis
In the last 4 quarters, NRXP has beaten EPS estimates in 1 out of 4 releases
NRXP has not beaten revenue estimates in any of the last 4 earnings releases
In the last 4 quarters, NRXP reported -216.3% below the EPS estimates on average.
In the last 4 quarters, NRXP reported -95.9% below the revenue estimates on average.
Related analysis
NRX PHARMACEUTICALS INC / NRXP Earnings FAQ
Did NRX PHARMACEUTICALS INC (NRXP) beat earnings estimates last quarter?
NRX PHARMACEUTICALS INC (NRXP) missed EPS estimates and missed revenue estimates in the most recent quarter.
How often does NRX PHARMACEUTICALS INC (NRXP) beat earnings estimates?
In the last 4 quarters, NRX PHARMACEUTICALS INC (NRXP) has beaten EPS estimates in 1 out of 4 releases.